Literature DB >> 17311249

DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation.

Veena Rajaram1, Stevan Knezevich, Kevin E Bove, Arie Perry, John D Pfeifer.   

Abstract

Undifferentiated embryonal sarcoma of the liver is a highly malignant and aggressive tumor that occasionally arises within mesenchymal hamartoma of the liver (MHL), a benign tumor that typically occurs in young children. Undifferentiated embryonal sarcoma arising in MHL, as well as uncomplicated MHL, frequently harbor rearrangements of band 19q13.4, including the translocation t(11;19)(q13;q13.4). In this study we report the cloning and DNA sequence analysis of the translocation breakpoints in an undifferentiated embryonal sarcoma arising in MHL known to harbor t(11;19). In this case, the breakpoint at 11q13 occurred in the MALAT1 gene, also known as ALPHA. MALAT1 is rearranged in renal tumors harboring the t(6;11)(p21;q13) translocation, and noncoding MALAT1 transcripts are overexpressed in a number of human carcinomas. The breakpoint at 19q13.4 occurs at a locus we refer to as MHLB1, for Mesenchymal Hamartoma of the Liver Breakpoint 1. Although the MHLB1 locus does not contain a known gene, several human ESTs map to the region (a subset of which show homology to the nuclear RNA export factor (NXF) gene family), and the region is conserved between many mammalian species. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311249     DOI: 10.1002/gcc.20437

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  32 in total

1.  Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes.

Authors:  Lucia Kato; Nasim A Begum; A Maxwell Burroughs; Tomomitsu Doi; Jun Kawai; Carsten O Daub; Takahisa Kawaguchi; Fumihiko Matsuda; Yoshihide Hayashizaki; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA.

Authors:  Jeremy E Wilusz; Susan M Freier; David L Spector
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

Review 3.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

Review 4.  Non-coding RNAs as theranostics in human cancers.

Authors:  Roxana S Redis; Ioana Berindan-Neagoe; Victor I Pop; George A Calin
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

5.  Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma.

Authors:  Lien Spans; Christopher Dm Fletcher; Cristina R Antonescu; Alexandre Rouquette; Jean-Michel Coindre; Raf Sciot; Maria Debiec-Rychter
Journal:  J Pathol       Date:  2016-05-20       Impact factor: 7.996

Review 6.  The long noncoding RNA Malat1: Its physiological and pathophysiological functions.

Authors:  Xuejing Zhang; Milton H Hamblin; Ke-Jie Yin
Journal:  RNA Biol       Date:  2017-10-06       Impact factor: 4.652

Review 7.  Long noncoding RNAs: Re-writing dogmas of RNA processing and stability.

Authors:  Jeremy E Wilusz
Journal:  Biochim Biophys Acta       Date:  2015-06-11

8.  The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult.

Authors:  Bin Zhang; Gayatri Arun; Yuntao S Mao; Zsolt Lazar; Gene Hung; Gourab Bhattacharjee; Xiaokun Xiao; Carmen J Booth; Jie Wu; Chaolin Zhang; David L Spector
Journal:  Cell Rep       Date:  2012-06-28       Impact factor: 9.423

9.  A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails.

Authors:  Jeremy E Wilusz; Courtney K JnBaptiste; Laura Y Lu; Claus-D Kuhn; Leemor Joshua-Tor; Phillip A Sharp
Journal:  Genes Dev       Date:  2012-10-16       Impact factor: 11.361

10.  Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications.

Authors:  Danyang Ren; Huiying Li; Renqiu Li; Jianming Sun; Pin Guo; Huiyun Han; Yuehuang Yang; Jun Li
Journal:  Oncol Lett       Date:  2016-01-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.